Centessa Pharmaceuticals plc (CNTA) has 17 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $0. Most recent filing: June 24, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| June 24, 2026 | Medicxi Ventures Management (Jersey) Ltd 10% Owner | $0 | 19,963,157 | −100% | No | |
|
|
||||||
| June 24, 2026 | INDEX VENTURES LIFE VI (JERSEY) L.P. 10% Owner | $0 | 9,961,789 | −100% | No | |
|
|
||||||
| June 24, 2026 | HUSSAIN IQBAL J Chief Legal Officer | $0 | 1,376,483 | −100% | No | |
|
|
||||||
| June 24, 2026 | Bush Tia L Chief Technology & Quality Ofc | $0 | 1,085,687 | −100% | No | |
|
|
||||||
| June 24, 2026 | Crowley John J Chief Financial Officer | $0 | 1,076,000 | −100% | No | |
|
|
||||||
Showing the 5 most recent of 17 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free